Comments
Loading...
Stime degli utili, EPS e fatturato
Milestone Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-0.170
Stima dei ricavi trimestrali
$400.00K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
–
Analizza lo storico degli utili di Milestone Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MIST | Milestone Pharmaceuticals | -$0.14 | -$0.17 | — | — | $0.00 | $400.00K | — | — | 11/11/2025 | |
MIST | Milestone Pharmaceuticals | -$0.14 | -$0.18 | -$0.20 | -11.11% | $0.00 | — | $0.00 | — | 08/12/2025 | |
MIST | Milestone Pharmaceuticals | -$0.21 | -$0.19 | -$0.31 | -63.16% | $0.00 | — | $0.00 | — | 05/14/2025 | |
MIST | Milestone Pharmaceuticals | -$0.32 | -$0.15 | -$0.19 | -26.67% | $0.00 | — | $0.00 | — | 03/13/2025 | |
MIST | Milestone Pharmaceuticals | -$0.35 | -$0.16 | -$0.14 | 12.50% | $0.00 | — | $0.00 | — | 11/12/2024 | |
MIST | Milestone Pharmaceuticals | -$0.37 | -$0.19 | -$0.14 | 26.32% | $0.00 | — | $0.00 | — | 08/08/2024 | |
MIST | Milestone Pharmaceuticals | -$0.35 | -$0.26 | -$0.21 | 19.23% | $1.00M | — | $0.00 | — | 05/13/2024 | |
MIST | Milestone Pharmaceuticals | -$0.31 | -$0.31 | -$0.32 | -3.23% | $3.50M | — | $0.00 | — | 03/21/2024 | |
MIST | Milestone Pharmaceuticals | -$0.34 | -$0.38 | -$0.35 | 7.89% | $1.50M | — | $0.00 | — | 11/13/2023 | |
MIST | Milestone Pharmaceuticals | -$0.39 | -$0.39 | -$0.37 | 5.13% | $0.00 | — | $0.00 | — | 08/10/2023 | |
MIST | Milestone Pharmaceuticals | -$0.33 | -$0.40 | -$0.35 | 12.50% | $0.00 | — | $1.00M | — | 05/11/2023 | |
MIST | Milestone Pharmaceuticals | -$0.40 | -$0.33 | -$0.31 | 6.06% | $0.00 | $870.00K | $3.50M | 302.30% | 03/29/2023 | |
MIST | Milestone Pharmaceuticals | -$0.34 | -$0.41 | -$0.34 | 17.07% | $0.00 | — | $1.50M | — | 11/10/2022 | |
MIST | Milestone Pharmaceuticals | $0.02 | -$0.36 | -$0.39 | -8.33% | $15.00M | — | $0.00 | — | 08/10/2022 | |
MIST | Milestone Pharmaceuticals | -$0.30 | -$0.39 | -$0.33 | 15.38% | $0.00 | — | $0.00 | — | 05/12/2022 | |
MIST | Milestone Pharmaceuticals | -$0.23 | -$0.36 | -$0.40 | -11.11% | $0.00 | — | $0.00 | — | 03/24/2022 | |
MIST | Milestone Pharmaceuticals | -$0.40 | -$0.38 | -$0.34 | 10.53% | $0.00 | — | $0.00 | — | 11/12/2021 | |
MIST | Milestone Pharmaceuticals | -$0.53 | -$0.26 | $0.02 | 107.69% | $0.00 | $3.00M | $15.00M | 400.00% | 08/11/2021 | |
MIST | Milestone Pharmaceuticals | -$0.67 | — | -$0.30 | — | $0.00 | — | $0.00 | — | 05/17/2021 | |
MIST | Milestone Pharmaceuticals | -$0.75 | — | -$0.23 | — | $0.00 | — | $0.00 | — | 03/29/2021 | |
MIST | Milestone Pharmaceuticals | -$0.52 | — | -$0.40 | — | $0.00 | — | $0.00 | — | 11/13/2020 |
Milestone Pharmaceuticals (MIST) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.20 | $-0.18 | -11.1 % |
| Q1 | 2025-05-14 | $-0.31 | $-0.19 | -63.2 % |
| Q4 | 2025-03-13 | $-0.19 | $-0.15 | -26.7 % |
| Q3 | 2024-11-12 | $-0.14 | $-0.16 | 12.5 % |
Milestone Pharmaceuticals (MIST) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | 2023-03-29 | $3.50M | $870.00K | 302.3 % |
| Q2 | 2021-08-11 | $15.00M | $3.00M | 400.0 % |
FAQ
Quando Milestone Pharmaceuticals (NASDAQ:MIST) riporterà gli utili?
Si prevede che Milestone Pharmaceuticals (MIST) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Milestone Pharmaceuticals (NASDAQ:MIST)?
L'EPS effettivo era $-0.20, che mancato la stima di $-0.18.
Quali sono state le entrate di Milestone Pharmaceuticals (NASDAQ:MIST)?
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.